For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there’s new hope. In a new study published in Cell...

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there’s new hope. In a new study published in Cell...

A cancer-targeting antibody that helps the body’s immune cells spot and destroy hard-to-treat tumours such as triple-negative breast cancer has been...

A cancer-targeting antibody that helps the body’s immune cells spot and destroy hard-to-treat tumours such as triple-negative breast cancer has been...

Highlights: LungVax trains the immune system to recognize abnormal lung cells Clinical trials begin in summer

Researchers at the University of California, San Diego School of Medicine, USA, have identified a promising new therapy for triple-negative breast...

Researchers at the University of California, San Diego School of Medicine, USA, have identified a promising new therapy for triple-negative breast...

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope.

For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope.

A groundbreaking clinical trial is underway in the UK for LungVax, an experimental vaccine designed to prevent lung cancer. This innovative approach...